| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hagerman Allison | VP, Product Development | C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO | /s/ Kirk Look, Attorney-in-Fact | 13 Feb 2026 | 0002103583 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ONCY | Common Shares | Purchase | $8,298 | +10,000 | +9.5% | $0.8298 | 115,059 | 12 Feb 2026 | Direct |